US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist

46.260
+0.120+0.26%

Close Dec 3 16:00 ET

45.700
-0.560-1.21%

Pre 06:38 ET

2.71BMarket Cap-17944P/E (TTM)

Apogee Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-113.90%-42.52M

-101.10%-29.3M

-199.67%-31.64M

-355.11%-74.76M

-223.80%-29.75M

-19.88M

-14.57M

-10.56M

-16.43M

-9.19M

Net income from continuing operations

-135.21%-49.02M

-79.06%-33.82M

-156.24%-32.09M

-111.10%-83.99M

-126.57%-31.74M

---20.84M

---18.89M

---12.53M

---39.79M

---14.01M

Depreciation and amortization

--48K

--36K

--29K

----

--0

----

Other non cash items

--387K

--280K

--266K

-99.24%87K

----

--11.4M

--563K

Change In working capital

1,290.10%3.73M

-51.84%1.54M

-289.19%-1.31M

-37.80%6.11M

19.36%2.52M

---313K

--3.2M

--694K

--9.82M

--2.11M

-Change in prepaid assets

-95.34%-2.81M

36.82%-1.21M

-3,222.73%-1.46M

-1,587.88%-2.79M

473.94%617K

---1.44M

---1.92M

---44K

---165K

-Change in payables and accrued expense

505.24%6.81M

-40.14%3.07M

-44.17%412K

-7.14%9.27M

0.18%2.28M

--1.13M

--5.12M

--738K

--9.98M

--2.28M

-Change in other current assets

---46K

----

---107K

--0

----

--0

----

-Change in other current liabilities

---229K

---244K

---263K

---270K

--0

----

Cash from discontinued investing activities

Operating cash flow

-113.90%-42.52M

-101.10%-29.3M

-199.67%-31.64M

-355.11%-74.76M

-223.80%-29.75M

---19.88M

---14.57M

---10.56M

---16.43M

---9.19M

Investing cash flow

Cash flow from continuing investing activities

37.50%-146.38M

-148.71M

-51.74M

-273.91M

-39.69M

-234.22M

Net PPE purchase and sale

---751K

---51K

---351K

---167K

--0

----

Net investment purchase and sale

37.82%-145.63M

---148.66M

---51.39M

---273.74M

---39.53M

---234.22M

--0

Cash from discontinued investing activities

Investing cash flow

37.50%-146.38M

---148.71M

---51.74M

---273.91M

---39.69M

---234.22M

--0

Financing cash flow

Cash flow from continuing financing activities

-99.88%383K

91.15%-150K

450.52M

87.38%315.39M

-100.13%-213K

317.3M

-1.69M

168.32M

158.5M

Net common stock issuance

--0

---541K

--450.5M

--315.39M

97.83%-213K

--315.6M

--0

---9.82M

Net preferred stock issuance

----

--0

----

--168.32M

----

Proceeds from stock option exercised by employees

--383K

--391K

--24K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-99.88%383K

91.15%-150K

--450.52M

87.38%315.39M

-100.13%-213K

--317.3M

---1.69M

--0

--168.32M

--158.5M

Net cash flow

Beginning cash position

145.94%307.59M

243.69%485.75M

-21.91%118.61M

--151.89M

7,188.77%188.27M

--125.07M

--141.33M

--151.89M

--0

--2.58M

Current changes in cash

-398.29%-188.52M

-995.41%-178.16M

3,577.70%367.14M

-121.91%-33.28M

-146.65%-69.66M

--63.2M

---16.26M

---10.56M

--151.89M

--149.31M

End cash Position

-36.75%119.07M

145.94%307.59M

243.69%485.75M

-21.91%118.61M

--188.27M

--125.07M

--141.33M

--151.89M

Free cash flow

-117.68%-43.28M

-101.45%-29.35M

-202.99%-31.99M

-356.13%-74.93M

-225.62%-29.92M

---19.88M

---14.57M

---10.56M

---16.43M

---9.19M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-113.90%-42.52M	-101.10%-29.3M	-199.67%-31.64M	-355.11%-74.76M	-223.80%-29.75M	-19.88M	-14.57M	-10.56M	-16.43M	-9.19M
Net income from continuing operations	-135.21%-49.02M	-79.06%-33.82M	-156.24%-32.09M	-111.10%-83.99M	-126.57%-31.74M	---20.84M	---18.89M	---12.53M	---39.79M	---14.01M
Depreciation and amortization	--48K	--36K	--29K	----	----	--0	--0	--0	----	----
Other non cash items	--387K	--280K	--266K	-99.24%87K	----	----	----	----	--11.4M	--563K
Change In working capital	1,290.10%3.73M	-51.84%1.54M	-289.19%-1.31M	-37.80%6.11M	19.36%2.52M	---313K	--3.2M	--694K	--9.82M	--2.11M
-Change in prepaid assets	-95.34%-2.81M	36.82%-1.21M	-3,222.73%-1.46M	-1,587.88%-2.79M	473.94%617K	---1.44M	---1.92M	---44K	---165K	---165K
-Change in payables and accrued expense	505.24%6.81M	-40.14%3.07M	-44.17%412K	-7.14%9.27M	0.18%2.28M	--1.13M	--5.12M	--738K	--9.98M	--2.28M
-Change in other current assets	---46K	----	----	---107K	---107K	--0	----	----	--0	----
-Change in other current liabilities	---229K	---244K	---263K	---270K	---270K	--0	--0	--0	--0	----
Cash from discontinued investing activities
Operating cash flow	-113.90%-42.52M	-101.10%-29.3M	-199.67%-31.64M	-355.11%-74.76M	-223.80%-29.75M	---19.88M	---14.57M	---10.56M	---16.43M	---9.19M
Investing cash flow
Cash flow from continuing investing activities	37.50%-146.38M	-148.71M	-51.74M	-273.91M	-39.69M	-234.22M	0	0	0	0
Net PPE purchase and sale	---751K	---51K	---351K	---167K	---167K	--0	--0	--0	--0	----
Net investment purchase and sale	37.82%-145.63M	---148.66M	---51.39M	---273.74M	---39.53M	---234.22M	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	37.50%-146.38M	---148.71M	---51.74M	---273.91M	---39.69M	---234.22M	--0	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-99.88%383K	91.15%-150K	450.52M	87.38%315.39M	-100.13%-213K	317.3M	-1.69M	0	168.32M	158.5M
Net common stock issuance	--0	---541K	--450.5M	--315.39M	97.83%-213K	--315.6M	--0	--0	--0	---9.82M
Net preferred stock issuance	----	----	----	--0	----	----	----	----	--168.32M	----
Proceeds from stock option exercised by employees	--383K	--391K	--24K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-99.88%383K	91.15%-150K	--450.52M	87.38%315.39M	-100.13%-213K	--317.3M	---1.69M	--0	--168.32M	--158.5M
Net cash flow
Beginning cash position	145.94%307.59M	243.69%485.75M	-21.91%118.61M	--151.89M	7,188.77%188.27M	--125.07M	--141.33M	--151.89M	--0	--2.58M
Current changes in cash	-398.29%-188.52M	-995.41%-178.16M	3,577.70%367.14M	-121.91%-33.28M	-146.65%-69.66M	--63.2M	---16.26M	---10.56M	--151.89M	--149.31M
End cash Position	-36.75%119.07M	145.94%307.59M	243.69%485.75M	-21.91%118.61M	-21.91%118.61M	--188.27M	--125.07M	--141.33M	--151.89M	--151.89M
Free cash flow	-117.68%-43.28M	-101.45%-29.35M	-202.99%-31.99M	-356.13%-74.93M	-225.62%-29.92M	---19.88M	---14.57M	---10.56M	---16.43M	---9.19M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data